HALOVSLEXX• 12 Months (Normalized)
HALO vs LEXX (Halozyme Therapeutics Inc. vs Lexaria Bioscience Corp.)
Showing Closing Date Range from Oct 6, 2025 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HALO Performance $108.31
+61.73%
Halozyme Therapeutics Inc.
Normalized Baseline0.00%
LEXX Performance $2.77
-78.02%
Lexaria Bioscience Corp.
Normalized Baseline0.00%
Alpha Spread Margin HALO LEADS
+139.75 pts
HALO outperforming by 139.75 percentage points
HALOLEXX
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HALO LEXX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | HALO Price | HALO Gain (%) | LEXX Price | LEXX Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $108.31 | +61.73% | $2.77 | -78.02% | +139.75% |
| Oct 02, 2026 | $109.86 | +64.04% | $2.88 | -77.14% | +141.18% |
| Oct 01, 2026 | $106.94 | +59.68% | $- | - | |
| Sep 30, 2026 | $110.40 | +64.85% | $3.15 | -75.00% | +139.85% |
| Sep 29, 2026 | $111.56 | +66.58% | $3.13 | -75.16% | +141.74% |
| Sep 28, 2026 | $112.89 | +68.57% | $3.23 | -74.40% | +142.97% |
| Sep 25, 2026 | $113.90 | +70.08% | $3.28 | -73.97% | +144.05% |
| Sep 24, 2026 | $- | $3.37 | -73.25% | - | |
| Sep 23, 2026 | $112.44 | +67.90% | $3.24 | -74.33% | +142.23% |
| Sep 22, 2026 | $115.13 | +71.91% | $- | - | |
| Sep 21, 2026 | $111.45 | +66.42% | $3.43 | -72.82% | +139.24% |
| Sep 18, 2026 | $112.45 | +67.91% | $3.24 | -74.29% | +142.20% |
| Sep 17, 2026 | $109.68 | +63.77% | $3.29 | -73.89% | +137.66% |
| Sep 16, 2026 | $108.44 | +61.92% | $3.10 | -75.44% | +137.36% |
| Sep 15, 2026 | $106.25 | +58.65% | $3.21 | -74.52% | +133.17% |
Page 1 of 17